11/11/2015 - 11:13am

Rapidly rising prices for many generics, regulations that could restrict patients’ access to these medications, a Food and Drug Administration backlog in getting new drugs approved and market consolidation that is reducing competition are all making some wonder how much longer generics will continue to be affordable.

11/10/2015 - 3:17pm

New Jersey Gov. Chris Christie this week signed legislation allowing pharmacists to subsistute FDA-approved biosimilar products for biologics, and Generic Pharmaceutical Association voiced its support for the move. 

11/10/2015 - 12:31pm

Teva Canada was granted approval for its Avelox generic by Health Canada on Tuesday. 

11/09/2015 - 11:17am

Glenmark Pharmaceuticals has gained approval from the FDA for its generic Lotrisone. 

11/05/2015 - 1:23pm

The new website is tailored to its user, with a product section that customizes results based on who is searching — patients, pharmacists or partners. 

11/03/2015 - 4:21pm

With the completion of this step all Mylan needs is word from Perrigo’s shareholders on whether or not they will accept the company’s $27 billion acquisition offer, which was tendered on Sept. 14. 

11/03/2015 - 2:31pm
The Regulartory Affairs Professionals Society is reporting that as part of the recently passed budget deal that the president signed Monday, generics companies whose prices rise beyond the Average Manufacturer Price that’s adjusted for inflation will have to pay higher rebates. “The amount of the rebate specified in this paragraph for a rebate period, with respect to each dosage form and strength of a covered outpatient drug other than a single source drug or an innovator multiple source drug of a manufacturer, shall be increased in the manner that the rebate for a dosage form and strength of a single source drug or an innovator multiple source drug is increased,” the act says. (RAPS)
11/03/2015 - 2:30pm

A new study by IMS Health for the Generic Pharmaceutical Association is highlighting the savings that generic drugs bring to patients. 

11/03/2015 - 2:23pm

Sun Pharmaceutical Industries has completed its acquisition of InSite Vision.